Resumen de acción NEULANDLAB
Neuland Laboratories Limited fabrica y vende principios activos farmacéuticos (API) en India, Europa, Estados Unidos y a escala internacional. Saber más
| Puntuación del snowflake | |
|---|---|
| Valoración | 1/6 |
| Crecimiento futuro | 5/6 |
| Rendimiento pasado | 4/6 |
| Salud financiera | 6/6 |
| Dividendos | 0/6 |
Competidores de Neuland Laboratories Limited
Historial de precios y rendimiento
| Precios históricos de las acciones | |
|---|---|
| Precio actual de la acción | ₹16,068.90 |
| Máximo en las últimas 52 semanas | ₹16,560.75 |
| Mínimo de 52 semanas | ₹4,926.05 |
| Beta | 0.98 |
| 1Cambio en 1 mes | 15.18% |
| Variación en 3 meses | 29.54% |
| Cambio de 1 año | 210.71% |
| 3Variación en 3 años | 813.32% |
| Variación en 5 años | 3,519.94% |
| Variación desde la OPV | 16,814.63% |
Noticias y actualizaciones recientes
Concerns Surrounding Neuland Laboratories' (NSE:NEULANDLAB) Performance
Nov 14
Neuland Laboratories Limited Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected
Nov 09Here's Why We Think Neuland Laboratories (NSE:NEULANDLAB) Is Well Worth Watching
Nov 08After Leaping 27% Neuland Laboratories Limited (NSE:NEULANDLAB) Shares Are Not Flying Under The Radar
Oct 17Recent updates
Concerns Surrounding Neuland Laboratories' (NSE:NEULANDLAB) Performance
Nov 14Neuland Laboratories Limited Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected
Nov 09Here's Why We Think Neuland Laboratories (NSE:NEULANDLAB) Is Well Worth Watching
Nov 08After Leaping 27% Neuland Laboratories Limited (NSE:NEULANDLAB) Shares Are Not Flying Under The Radar
Oct 17Neuland Laboratories Limited's (NSE:NEULANDLAB) Shares Climb 44% But Its Business Is Yet to Catch Up
Aug 22Is Now The Time To Put Neuland Laboratories (NSE:NEULANDLAB) On Your Watchlist?
Aug 02Neuland Laboratories' (NSE:NEULANDLAB) Dividend Will Be Increased To ₹14.00
Jul 12Optimistic Investors Push Neuland Laboratories Limited (NSE:NEULANDLAB) Shares Up 28% But Growth Is Lacking
Jul 02Neuland Laboratories' (NSE:NEULANDLAB) Upcoming Dividend Will Be Larger Than Last Year's
Jun 19Is Neuland Laboratories (NSE:NEULANDLAB) Using Too Much Debt?
Jun 12Neuland Laboratories (NSE:NEULANDLAB) Will Pay A Larger Dividend Than Last Year At ₹14.00
May 21There's Reason For Concern Over Neuland Laboratories Limited's (NSE:NEULANDLAB) Massive 25% Price Jump
Apr 19We Ran A Stock Scan For Earnings Growth And Neuland Laboratories (NSE:NEULANDLAB) Passed With Ease
Apr 15Subdued Growth No Barrier To Neuland Laboratories Limited (NSE:NEULANDLAB) With Shares Advancing 29%
Feb 17Revenue Beat: Neuland Laboratories Limited Exceeded Revenue Forecasts By 8.1% And Analysts Are Updating Their Estimates
Feb 12Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly
Jan 05The Neuland Laboratories Limited (NSE:NEULANDLAB) Analyst Just Boosted Their Forecasts By A Meaningful Amount
Nov 12Here's Why We Think Neuland Laboratories (NSE:NEULANDLAB) Might Deserve Your Attention Today
Oct 27Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly
Aug 24Forecast: Analysts Think Neuland Laboratories Limited's (NSE:NEULANDLAB) Business Prospects Have Improved Drastically
Aug 05Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00
Jul 05Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00
Jun 21Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00
May 14Should You Be Adding Neuland Laboratories (NSE:NEULANDLAB) To Your Watchlist Today?
May 12Here's Why Neuland Laboratories (NSE:NEULANDLAB) Can Manage Its Debt Responsibly
Aug 30I Built A List Of Growing Companies And Neuland Laboratories (NSE:NEULANDLAB) Made The Cut
Feb 23The Consensus EPS Estimates For Neuland Laboratories Limited (NSE:NEULANDLAB) Just Fell Dramatically
Feb 03Rentabilidad de los accionistas
| NEULANDLAB | IN Pharmaceuticals | Mercado IN | |
|---|---|---|---|
| 7D | 7.9% | 1.1% | 2.0% |
| 1Y | 210.7% | 43.3% | 28.6% |
Rentabilidad vs. Industria: NEULANDLAB superó a la industria Indian Pharmaceuticals, que obtuvo un rendimiento del 43.3% el año pasado.
Rentabilidad vs. Mercado: NEULANDLAB superó al mercado Indian, que obtuvo un rendimiento del 28.6% el año pasado.
Volatilidad de los precios
| NEULANDLAB volatility | |
|---|---|
| NEULANDLAB Average Weekly Movement | 9.4% |
| Pharmaceuticals Industry Average Movement | 6.1% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Precio estable de las acciones: El precio de las acciones de NEULANDLAB ha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de NEULANDLAB(9%) se ha mantenido estable durante el último año, pero sigue siendo superior al 75% de las acciones de Indian.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1984 | 1,643 | Davuluri Rao | www.neulandlabs.com |
Neuland Laboratories Limited fabrica y vende principios activos farmacéuticos (API) en India, Europa, Estados Unidos y a escala internacional. También ofrece soluciones de fabricación a medida, así como servicios de síntesis de péptidos. Neuland Laboratories Limited se constituyó en 1984 y tiene su sede en Hyderabad (India).
Resumen de fundamentos de Neuland Laboratories Limited
| Estadísticas fundamentales de NEULANDLAB | |
|---|---|
| Capitalización bursátil | ₹206.36b |
| Beneficios(TTM) | ₹2.80b |
| Ingresos (TTM) | ₹15.28b |
73.8x
Ratio precio-beneficio (PE)13.5x
Ratio precio-ventas (PS)¿Está NEULANDLAB sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de NEULANDLAB | |
|---|---|
| Ingresos | ₹15.28b |
| Coste de los ingresos | ₹7.31b |
| Beneficio bruto | ₹7.97b |
| Otros gastos | ₹5.17b |
| Beneficios | ₹2.80b |
Últimos beneficios comunicados
Sep 30, 2024
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 217.98 |
| Margen bruto | 52.14% |
| Margen de beneficio neto | 18.30% |
| Ratio deuda/patrimonio | 6.7% |
¿Cómo se ha desempeñado NEULANDLAB a largo plazo?
Ver rendimiento histórico y comparativa